B. Duncan
The Lancet · 2002–2023
A researcher in the Science corpus: 18 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from B. Duncan's perspective
Ordered by how strongly the researchers B. Duncan trusts endorse each paper. Same corpus, a different order for every researcher.
- C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (Journal of the American Medical Association (JAMA))
- Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
- Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ (Proceedings of the Nutrition Society)
- Adiponectin and development of type 2 diabetes in the Pima Indian population. (The Lancet)
- Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 (Nature Medicine)
- Hyperglycemia and Adverse Pregnancy Outcomes
- Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. (Diabetes)
- Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. (American Journal of Epidemiology)
- Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research,… (HYPERTENSION)
- C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. (Diabetes)
Their papers
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 (2023) — 2,755 citations
- Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 (2022) — 1,391 citations
- Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. (2022) — 692 citations
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 (2021) — 8,497 citations
- Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019 (2021) — 757 citations
- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) — 1,072 citations
- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2020) — 4,321 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) — 2,198 citations
- Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. (2018) — 844 citations
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 4,276 citations
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 632 citations
- Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) — 4,590 citations
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. (2016) — 5,345 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015 (2016) — 1,771 citations
- Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria (2012) — 596 citations
- Chronic non-communicable diseases in Brazil: burden and current challenges. (2011) — 1,217 citations
- Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. (2003) — 1,049 citations
- Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. (2002) — 8,521 citations